CRISPR Therapeutics (CRSP) News Today $56.80 -2.20 (-3.73%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$56.40 -0.39 (-0.70%) As of 07/11/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRSP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Leavell Investment Management Inc. Invests $340,000 in CRISPR Therapeutics AG (NASDAQ:CRSP)4 hours ago | marketbeat.com12,223 Shares in CRISPR Therapeutics AG (NASDAQ:CRSP) Acquired by B & T Capital Management DBA Alpha Capital ManagementJuly 12 at 7:54 AM | marketbeat.comCRISPR Therapeutics' (CRSP) Buy Rating Reiterated at Needham & Company LLCJuly 11 at 2:11 AM | americanbankingnews.comCRISPR Stock Surges in Recent Weeks: What's Going On?July 10 at 2:38 PM | benzinga.comCRISPR Therapeutics (CRSP) Jumps 9.6% on Biotech RallyJuly 10 at 9:31 AM | msn.comCRISPR Therapeutics (NasdaqGM:CRSP) Advances Cardiovascular Programs With Promising Trial ResultsJuly 10 at 4:30 AM | finance.yahoo.comCRISPR Therapeutics Sees Unusually Large Options Volume (NASDAQ:CRSP)July 9, 2025 | marketbeat.comCathie Wood’s ARK buys CRSP stock, sells ROKU and MASSJuly 8, 2025 | investing.comCRISPR Therapeutics (NASDAQ:CRSP) Stock Price Up 7% - Time to Buy?July 8, 2025 | marketbeat.comCRISPR Therapeutics' (CRSP) Buy Rating Reaffirmed at Needham & Company LLCJuly 8, 2025 | marketbeat.comCRISPR Therapeutics AG (NASDAQ:CRSP) Shares Sold by KBC Group NVJuly 8, 2025 | marketbeat.comCambridge Investment Research Advisors Inc. Grows Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)July 4, 2025 | marketbeat.comCRSP - CRISPR Therapeutics AG Sustainability - MorningstarJuly 3, 2025 | morningstar.comMH.C. Wainwright Reaffirms Buy Rating on CRISPR Therapeutics After CTX310 UpdateJuly 3, 2025 | msn.com2 Beaten-Down Stocks With Massive Upside PotentialJuly 3, 2025 | fool.com2 Growth Stocks to Buy Hand Over Fist in JulyJuly 2, 2025 | fool.comCRISPR Therapeutics Named to TIME’s Most Influential Companies List of 2025June 30, 2025 | finance.yahoo.comCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 7.1% - Should You Buy?June 30, 2025 | marketbeat.comSumitomo Mitsui Trust Group Inc. Sells 205,787 Shares of CRISPR Therapeutics AG (NASDAQ:CRSP)June 30, 2025 | marketbeat.comPiper Sandler Remains a Buy on Crispr Therapeutics AG (CRSP)June 29, 2025 | theglobeandmail.comCRSP - CRISPR Therapeutics AG Ownership - MorningstarJune 28, 2025 | morningstar.comMClear Street Downgrades CRISPR Therapeutics (CRSP)June 28, 2025 | msn.comWealth Enhancement Advisory Services LLC Increases Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)June 28, 2025 | marketbeat.comCRISPR Therapeutics AG (CRSP) Stock Moves 1.88%: What You Should KnowJune 27, 2025 | finance.yahoo.comCRSP CRISPR Therapeutics AG - Seeking AlphaJune 27, 2025 | seekingalpha.comPiper Sandler Reaffirms "Overweight" Rating for CRISPR Therapeutics (NASDAQ:CRSP)June 27, 2025 | marketbeat.comJMP Securities Reaffirms "Market Outperform" Rating for CRISPR Therapeutics (NASDAQ:CRSP)June 27, 2025 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Earns "Buy" Rating from HC WainwrightJune 27, 2025 | marketbeat.comCRISPR Therapeutics (NasdaqGM:CRSP) Announces Promising Data From Cardiovascular Disease ProgramsJune 26, 2025 | finance.yahoo.comNeedham & Company LLC Reaffirms Buy Rating for CRISPR Therapeutics (NASDAQ:CRSP)June 26, 2025 | marketbeat.comCRISPR Therapeutics' (CRSP) "Buy" Rating Reaffirmed at Chardan CapitalJune 26, 2025 | marketbeat.comCRISPR Therapeutics Reports Positive Additional Phase 1 Data for CTX310™ Targeting ANGPTL3 and Provides Update on In Vivo Cardiovascular PipelineJune 26, 2025 | globenewswire.comIs CRISPR Therapeutics AG (NASDAQ:CRSP) Trading At A 45% Discount?June 25, 2025 | finance.yahoo.comCRISPR Therapeutics AG (CRSP): A Bull Case TheoryJune 24, 2025 | insidermonkey.comThe Best Stocks to Invest $1,000 in Right NowJune 24, 2025 | fool.comCrispr Therapeutics AG (CRSP) Gets a Hold from BernsteinJune 21, 2025 | theglobeandmail.com2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street AnalystsJune 21, 2025 | fool.comCrispr Therapeutics: Face The Harsh Reality Instead Of Waiting (Rating Downgrade)June 21, 2025 | seekingalpha.comCRISPR Therapeutics AG (NASDAQ:CRSP) Given Average Recommendation of "Hold" by BrokeragesJune 21, 2025 | marketbeat.comTraders Buy High Volume of Call Options on CRISPR Therapeutics (NASDAQ:CRSP)June 18, 2025 | marketbeat.comSG Americas Securities LLC Grows Position in CRISPR Therapeutics AG (NASDAQ:CRSP)June 18, 2025 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Shares Gap Up - Should You Buy?June 17, 2025 | marketbeat.comCan a $10,000 Investment in CRISPR Therapeutics Turn Into $1 Million?June 15, 2025 | 247wallst.comCrispr Therapeutics: Betting On A One-Shot FutureJune 13, 2025 | seekingalpha.comAvanza Fonder AB Makes New $866,000 Investment in CRISPR Therapeutics AG (NASDAQ:CRSP)June 13, 2025 | marketbeat.comCrispr extends gains for the seventh consecutive trading dayJune 11, 2025 | msn.comMillennium Management LLC Trims Stock Holdings in CRISPR Therapeutics AG (NASDAQ:CRSP)June 11, 2025 | marketbeat.comCRISPR Therapeutics (NASDAQ:CRSP) Trading Up 6% - Here's WhyJune 10, 2025 | marketbeat.comBrokers Issue Forecasts for CRSP FY2026 EarningsJune 10, 2025 | marketbeat.comCRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)June 9, 2025 | seekingalpha.com Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address CRSP Media Mentions By Week CRSP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRSP News Sentiment▼0.610.99▲Average Medical News Sentiment CRSP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRSP Articles This Week▼1311▲CRSP Articles Average Week Get CRISPR Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CRSP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Allogene Therapeutics News Axsome Therapeutics News Beam Therapeutics News Editas Medicine News KALA BIO News Moderna News Intellia Therapeutics News Vertex Pharmaceuticals News Summit Therapeutics News Intra-Cellular Therapies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRSP) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CRISPR Therapeutics AG Please log in to your account or sign up in order to add this asset to your watchlist. Share CRISPR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
